Radiothérapie métabolique = ImmunoradiotherapySIBILOT, D. Moro; VUILLEZ, J. P.Revue des maladies respiratoires. Supplément. 2001, Vol 18, Num 1, pp 1S133-1S134, issn 1166-8253Article

The radioisotope contributes significantly to the activity of radioimmunotherapyDAVIS, Thomas A; KAMINSKI, Mark S; LEVY, Ronald et al.Clinical cancer research. 2004, Vol 10, Num 23, pp 7792-7798, issn 1078-0432, 7 p.Article

Comparisons of sectioned micro-TLD dose measurements with predicted dose from ¹³¹I-labeled antibodyLANGMUIR, V. K; WESSELS, B. W; MENDONCA, H et al.Medical physics (Lancaster). 1992, Vol 19, Num 5, pp 1213-1218, issn 0094-2405Article

In vivo diagnosis and therapy of human tumors with monoclonal antibodies. II, Naples, Italy, 16-19 March 1988ECKELMAN, W. C; LARSON, S. M.Nuclear medicine and biology. 1989, Vol 16, Num 6, issn 0969-8051, I.VI, 613-668 [62 p.]Conference Proceedings

Pretargeted α emitting radioimmunotherapy using ²¹³Bi 1,4,7,10-tetraazacyclododecane-N, N', N, N'''-tetraacetic acid-biotinZHENGSHENG YAO; MEILI ZHANG; PASTAN, Ira et al.Clinical cancer research. 2004, Vol 10, Num 9, pp 3137-3146, issn 1078-0432, 10 p.Article

Intraperitoneal pretarget radioimmunotherapy with CC49 fusion proteinBUCHSBAUM, Donald J; KHAZAELI, M. B; AXWORTHY, Donald B et al.Clinical cancer research. 2005, Vol 11, Num 22, pp 8180-8185, issn 1078-0432, 6 p.Article

Radioimmunotherapy of malignancy using antibody targeted radionuclidesCOBB, L. M; HUMM, J. L.British journal of cancer. 1986, Vol 54, Num 6, pp 863-870, issn 0007-0920Article

Sacral scintigraphy for bone marrow dosimetry in radioimmunotherapySIEGEL, J. A; LEE, R. E; PAWLYK, D. A et al.Nuclear medicine and biology. 1989, Vol 16, Num 6, pp 553-559, issn 0969-8051, 6 p.Article

Progress in radioimmunotherapyBAST, R. C.The New England journal of medicine. 1993, Vol 329, Num 17, pp 1266-1268, issn 0028-4793Article

Strategies for enhancement of radioimmunotherapyDENARDO, G; DENARDO, S; KUKIS, D et al.International journal of radiation applications and instrumentation. Part B. Nuclear medicine and biology. 1991, Vol 18, Num 6, pp 633-640, issn 0883-2897, 7 p.Conference Paper

New concepts in monoclonal antibody based radioimmunodiagnosis and radioimmunotherapy of carcinomaSCHLOM, J; MILENIC, D. E; ROSELLI, M et al.International journal of radiation applications and instrumentation. Part B. Nuclear medicine and biology. 1991, Vol 18, Num 4, pp 425-435, issn 0883-2897, 9 p.Conference Paper

Feasibility of radioimmunotherapy of experimental pneumococcal infectionDADACHOVA, E; BURNS, T; BRYAN, R. A et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 5, pp 1624-1629, issn 0066-4804, 6 p.Article

Radioimmunotherapy of cancer : arming the missilesGOLDENBERG, D. M; GRIFFITHS, G. L.JNM : (1990). 1992, Vol 33, Num 6, pp 1110-1112Article

Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbuminVERA, D. R; STADALNIK, R. C; TRUDEAU, W. L et al.JNM. Journal of nuclear medicine (The) : (1990). 1991, Vol 32, Num 6, pp 1169-1176Article

Optimizing antibodies for use in nuclear medicineKASSIS, A. I.JNM. Journal of nuclear medicine (The) : (1990). 1991, Vol 32, Num 9, pp 1751-1753Article

Nonantigen-specific tissue localization of monoclonal antibodiesMASSUGER, L; CLAESSENS, R; KENEMANS, P et al.The Journal of nuclear medicine (1978). 1990, Vol 31, Num 8, issn 0161-5505, p. 1438Article

Radioactive gold cluster immunocongugates: potential agents for cancer therapyHAINFELD, J. F; FOLEY, C. J; SRIVASTAVA, S. C et al.International journal of radiation applications and instrumentation. Part B. Nuclear medicine and biology. 1990, Vol 17, Num 3, pp 287-294, issn 0883-2897, 7 p.Article

Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-D-glucose results in reduction of therapeutic efficacyDEARLING, Jason L. J; QURESHI, Uzma; BEGENT, Richard H. J et al.Clinical cancer research. 2007, Vol 13, Num 6, pp 1903-1910, issn 1078-0432, 8 p.Article

A technical analysis of an intraoperative radiation detection probeWILSON, L. A; KUHN, J. A; CORBISIERO, R. M et al.Medical physics (Lancaster). 1992, Vol 19, Num 5, pp 1219-1223, issn 0094-2405Article

Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1,k 17-1A monoclonal antibodyMEREDITH, R. F; LOBUGLIO, A. F; WHEELER, R. H et al.JNM. Journal of nuclear medicine (The) : (1990). 1991, Vol 32, Num 6, pp 1162-1168Article

Macroscopic dosimetry for radioimmunotherapy: nonuniform activity distributions in solid tumorsHOWELL, R. W; RAO, D. V; SASTRY, K. S. R et al.Medical physics (Lancaster). 1989, Vol 16, Num 1, pp 66-74, issn 0094-2405, 9 p.Article

Radioimmunotherapy of Fibroblast Activation Protein Positive Tumors by Rapidly Internalizing AntibodiesFISCHER, Eliane; CHAITANYA, Krishna; WÜEST, Thomas et al.Clinical cancer research (Print). 2012, Vol 18, Num 22, pp 6208-6218, issn 1078-0432, 11 p.Article

Optimization of radioimmunotherapy of solid tumors : Biological impediments and their modulationJAIN, Maneesh; VENKATRAMAN, Ganesh; BATRA, Surinder K et al.Clinical cancer research. 2007, Vol 13, Num 5, pp 1374-1382, issn 1078-0432, 9 p.Article

Conference on radioimmunodetection and radioimmunotherapy of cancerGOLDENBERG, David M.Cancer. 1994, Vol 73, Num 3, issn 0008-543X, SUPConference Proceedings

Selection of radionuclides for radioimmunotherapyMAUSNER, L. F; SRIVASTAVA, S. C.Medical physics (Lancaster). 1993, Vol 20, Num 2, pp 503-509, issn 0094-2405, 2Article